Concepedia

Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro

Anne Marie Queenan, David J. Dowling, Wing Ki Cheng, Kellen C. Faé, Jeffrey Fernandez, Peter J. Flynn, Sweta Joshi, Spencer E. Brightman, Juan Camilo Ramírez, Jan Serroyen,

Vaccine · 2018 · 20 citations · 30 references

DOIFull text

Open access

Concepts

References

30

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

Carol Kilkenny, William J. Browne, Innes C. Cuthill et al. · PLoS Biology · 2010 · 7.3K citations · Full text

, , +12

Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research

Carol Kilkenny, William J. Browne, Innes C. Cuthill et al. · Journal of Pharmacology and Pharmacotherapeutics · 2010 · 6.3K citations · Full text

, , +12

A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine

Lennart Gustafsson, Hans O. Hallander, P Olin et al. · New England Journal of Medicine · 1996 · 734 citations · Full text

, , +14

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

Jann Storsæter, Hans O. Hallander, Lennart Gustafsson et al. · Vaccine · 1998 · 486 citations

, , +10

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine

P Olin, Finn Rasmussen, Lea Nørgreen Gustafsson et al. · The Lancet · 1997 · 331 citations

, , +13